Browse by Disease Classification

This page shows data for Hemorrhagic Disease Classification.
Total Entries Retrieved: 23
IDVaccine NameDisease NameDisease ClassificationVirus NameNucleic Acid ContentVaccine TypeVaccine StatusManufacturerYear of ManufacturingManufacturing CountryAgeDosageAdministration RouteAdjuvantTarget StrainDescriptionApproving OrganisationCollaborating OrganisationOther CountriesTrade NamePMIDClinical Trial IDReference LinkAdditional Links
10084 ERVEBO Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Live-attenuated Approved Merck & Co. Inc. 2019 USA 18 years and above Single dose Intramuscular NA Zaire Ebola virus glycoprotein NA US FDA, EMA NA NA V920, rVSV-G-ZEBOV-GP, rVSV-ZEBOV NA NA https://www.cdc.gov/vhf/ebola/clinicians/vaccine/index.html https://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2817%2930313-4/fulltext
10085 Ad26.ZEBOV Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Recombinant viral vector Approved Janssen Pharmaceutical 2020 USA 1 year and above Single dose of Zabdeno on day 0 followed by 0.5mL dose of Mvabea post 8 week Intramuscular NA Adenovirus type 26 encoding the Zaire ebolavirus, Mayinga variant glycoprotein NA US FDA, EMA NA NA MVA-BN-Filo NA NCT02509494 https://clinicaltrials.gov/ct2/show/NCT02509494 https://clinicaltrials.gov/ct2/show/NCT05284097
10086 YF-Vax Yellow fever Hemorrhagic Yellow fever virus positive-sense, single-stranded RNA Live-attenuated Approved Sanofi Pasteur NA France 9 months and above Single dose Subcutaneous NA 17D-204 strain of yellow fever virus Culturing 17D-204 strain of yellow fever virus in living avian leukosis virus-free (ALV-free) chicken embryos US FDA NA NA NA NA NA https://www.fda.gov/media/76015/download https://www.fda.gov/media/76015/download
10087 CYD-TDV Dengvaxia Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Live-attenuated Approved Sanofi Pasteur 2015 France 9 - 45 years 3 doses 6 months apart Subcutaneous NA Dengue virus serotypes (1, 2, 3 and 4) 17D vaccine vector expressing genes of DENV-1, 2, 3, or 4 US FDA NA NA NA 30684747 NCT02747927 https://www.sciencedirect.com/science/article/pii/S1201971219300402 https://www.fda.gov/media/124379/download
10200 Ad5-EBOV Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Non-replicating viral vector Phase 1 National Institute of Health 2010 USA 18 - 50 years NA Intramuscular NA Ebola virus envelope glycoprotein NA NA National Institute of Allergy and Infectious Diseases NA NA 27764560 NCT00374309 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287303/ https://www.precisionvaccinations.com/vaccines/ad5-ebov-ebola-vaccine#:~:text=CanSinBio%20Ad5%2DEBOV%20is%20an,type%2D5%20vector%20immune%20response.
10201 DNA Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA DNA based vaccine Phase 1 National Institute of Health 2003 USA 18 - 44 years NA NA NA NA NA NA National Institute of Allergy and Infectious Diseases NA NA 27764560 NCT00072605 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287303/ NA
10202 rVSV-EBOV Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Recombinant viral vector Phase 1 Merck & Co. Inc. 2014 USA 18 - 65 years NA Intramuscular NA Zaire Ebola virus glycoprotein Vesicular Stomatitis Virus based NA National Institute of Allergy and Infectious Diseases NA NA 27764560 NCT02280408 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287303/ NA
10203 Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO)/ChAd3-EBO-Z Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Recombinant viral vector Phase 1 National Institute of Allergy and Infectious Diseases 2014 USA 18 - 65 years NA Intramuscular NA Wild type glycoproteins from Zaire and Sudan strains of Ebolavirus Chimpanzee Adenovirus Vector expressing Zaire and sudan strain glycoprotein NA NA NA NA 27764560 NCT02231866 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287303/ NA
10204 HPIV3-EBO-Z ( HPIV3-EbovZ GP Vaccine) Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Virus like particle Phase 1 Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health 2015 USA 18 - 50 years NA Intranasal NA Zaire Ebola virus glycoprotein Live-attenuated human Parainfluenza virus type 3 vectored vaccine expressing Ebolavirus Zaire glycoprotein NA National Institute of Allergy and Infectious Diseases NA NA 27764560 NCT02564575 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287303/ NA
10205 KIRIM-KONGO-VAX Crimean-Congo haemorrhagic fever Hemorrhagic Nairovirus negative-sense, single-stranded RNA NA Phase 1 The Scientific and Technological Research Council of Turkey 2017 Turkey 18 - 55 years NA Subcutaneous, Intramuscular NA NA NA NA NA NA NA NA NCT03020771 https://clinicaltrials.gov/ct2/show/NCT03020771?cond=Crimean-Congo+hemorrhagic+fever&draw=2&rank=1 https://ichgcp.net/clinical-trials-registry/NCT03020771
10206 GEO-EM05 Marburg hemorrhagic fever Hemorrhagic Marburg virus negative-sense, single-stranded RNA Virus like particle Phase 1 GeoVax Labs Inc. NA USA NA NA Intramuscular NA NA NA NA NA NA NA NA NA https://www.biospace.com/article/geovax-announces-100-percent-protection-data-from-marburg-virus-vaccine-study/ NA
10207 AVI-6003 Marburg hemorrhagic fever Hemorrhagic Marburg virus negative-sense, single-stranded RNA NA Phase 1 Sarepta Therapeutics Inc. 2012 USA 18 - 55 years NA Intravenous NA NA NA NA NA NA NA NA NCT01353040 https://clinicaltrials.gov/ct2/show/NCT01353040?cond=Marburg+hemorrhagic+fever&draw=2&rank=1 NA
10208 cAd3 Marburg (VRC-MARADC087-00-VP) Marburg hemorrhagic fever Hemorrhagic Marburg virus negative-sense, single-stranded RNA Recombinant viral vector Phase 1 National Institute of Allergy and Infectious Diseases 2021 USA 18 - 50 years Single dose Intramuscular NA Marburg wild type glycoprotein NA US FDA US Military HIV Research Program NA NA NA NCT03475056 https://clinicaltrials.gov/ct2/show/NCT03475056?cond=Marburg+hemorrhagic+fever&draw=2&rank=3 NA
10209 XRX-001 Inactivated yellow fever vaccine Yellow fever Hemorrhagic Yellow fever virus positive-sense, single-stranded RNA Inactivated Phase 1 GE Healthcare 2016 USA 18 - 49 years NA NA Aluminum (alum) Yellow fever virus NA NA NA NA NA NA NCT00995865 https://clinicaltrials.gov/ct2/show/NCT00995865?recrs=abde&cond=yellow+fever&phase=0123&draw=2&rank=4 NA
10210 DENV-1 PIV Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Inactivated Phase 1 US Army Medical Research and Development Command 2015 USA 18 - 50 years 2 doses 28 days apart Intramuscular NA Dengue virus serotypes -1 NA NA NA NA NA NA NCT01502735 https://clinicaltrials.gov/ct2/show/NCT01502735?recrs=abde&cond=dengue+fever&phase=0123&draw=2&rank=5 NA
10211 rDEN3delta30/31-7164 Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Live-attenuated Phase 1 National Institute of Allergy and Infectious Diseases 2013 USA 18 - 50 years NA Subcutaneous NA Dengue virus serotypes -3 NA NA Johns Hopkins Bloomberg School of Public Health NA NA NA NCT00831012 https://clinicaltrials.gov/ct2/show/NCT00831012?recrs=abde&cond=dengue+fever&phase=0123&draw=2&rank=12 NA
10212 MV-LASV (V182-001) Lassa fever Hemorrhagic Lassa virus negative-sense, single-stranded RNA Live-attenuated Phase 1 Themis Bioscience 2021 Belgium 18 - 55 years 2 doses 28 days apart Intramuscular NA Measles Schwarz virus strain for prophylaxis of Lassa infection NA NA NA NA NA NA NCT04055454 https://clinicaltrials.gov/ct2/show/NCT04055454?cond=Lassa+fever&draw=2&rank=10 NA
10294 cAd3-EBO Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Recombinant viral vector Phase 2 Centre Hospitalier Universitaire Vaudois 2014 Switzerland 18 - 65 years NA Intramuscular NA Zaire Ebola virus glycoprotein Chimpanzee Adenovirus Vector expressing Zaire strain glycoprotein NA NA NA NA 27764560 NCT02289027 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287303/ NA
10295 DSV4 Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Subunit vaccine Phase 2 Panacea Biotec Ltd NA India 2 - 60 years NA NA NA Chimeric protein containing vHBsAg,DS, unique tetravalent dengue antigen Produced using the methylotrophic yeast Pichia pastoris NA NA NA NA 30684747 NA https://www.sciencedirect.com/science/article/pii/S1201971219300402 NA
10363 STAMARiL Yellow fever Hemorrhagic Yellow fever virus positive-sense, single-stranded RNA Live-attenuated Phase 3 Sanofi Pasteur NA France 10 months Single dose Subcutaneous NA 17D-204 strain of yellow fever virus Produced in specified pathogen-free chick embryos NA NA NA NA NA NA https://www.sanofipasteur.co.uk/-/media/ems/conditions/vaccines/brands/oneportal-ie/pdf/105_stamaril_mah_address_update_12_2017_uk.pdf NA
10364 TAK-003 Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Live-attenuated Phase 3 Takeda Pharmaceutical Company Limited NA USA 4 - 16 years NA Subcutaneous NA Dengue virus serotypes (1, 2, 3 and 4) Mammalian cell vero culture NA NA NA TDV 30684747 NA https://www.sciencedirect.com/science/article/pii/S1201971219300402 NA
10365 TV-003/005 Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Live-attenuated Phase 3 Merck & Co. Inc. NA Brazil 2 - 59 years NA Subcutaneous NA Dengue virus serotypes (1, 2, 3 and 4) Mammalian cell vero culture NA National Institute of Allergy and Infectious Diseases NA TetraVax-DV 30684747 NCT02406729 https://www.sciencedirect.com/science/article/pii/S1201971219300402 https://clinicaltrials.gov/ct2/show/NCT02406729
10379 Bulgarian vaccine Crimean-Congo haemorrhagic fever Hemorrhagic Nairovirus negative-sense, single-stranded RNA Inactivated Preclinical NA 1974 Union of Soviet Socialist Republics 16 years and above NA Subcutaneous Aluminum (aluminium hydroxide) NA Prepared from brain tissue of CCHFV infected newborn mice NA NA NA Zabdeno, Mvabea 32461819 NA https://www.liebertpub.com/doi/10.1089/biores.2019.0057 https://www.ema.europa.eu/en/documents/product-information/zabdeno-epar-product-information_en.pdf